In the U.S., Wegovy tablets are FDA-approved for chronic weight management
Expanded approvals : Trials are ongoing for fatty liver disease, cardiovascular prevention in non-diabetics, and neurodegenerative disorders
They also appear to offer protective benefits for vital organs including the heart, liver, and kidneys
GLP-1 receptor agonists stimulate insulin secretion, suppress glucagon release, and slow gastric emptying to control blood glucose and support weight management
Why It Works: Ketones suppress ghrelin, and fats slow digestion keeps you satiatedideal post-GLP-1
One of the treatments we consider in our personalized healthcare plans is the use of Glucagon-like peptide-1 (GLP-1) injections